Comparing the Efficacy and Tolerability of a New Daily Oral Vitamin B12 Formulation and Intermittent Intramuscular Vitamin B12 in Normalizing Low Cobalamin Levels: A Randomized, Open-Label, Parallel-Group Study

Clinical Therapeutics

Volumn 33, Issue 3, 2011, Pages

  Castelli, M Cristina ^a   Friedman, Kristen ^a   Sherry, James ^a   Brazzillo, Karen ^a   Genoble, Lise ^a   Bhargava, Prateek ^a   Riley, M Gary I ^a  

^a Emisphere Technologies   (United States)

Author keywords

Cobalamin; Deficiency; Eligen; Holotranscobalamin; Homocysteine; Intramuscular; Methylmalonic acid; SNAC

Indexed keywords

COBALAMIN; CYANOCOBALAMIN; HOMOCYSTEINE; METHYLMALONIC ACID; TRANSCOBALAMIN II;

ABSCESS; ADULT; AGED; ARTHRALGIA; ARTICLE; BACKACHE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIARRHEA; DIET RESTRICTION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; LYME DISEASE; MALE; OUTCOME ASSESSMENT; PAIN; RANDOMIZED CONTROLLED TRIAL; SINUS HEADACHE; STATISTICAL SIGNIFICANCE; VITAMIN BLOOD LEVEL;

EID: 79956034372     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2011.03.003     Document Type: Article

References (33)

1. Hvas A.M., Nexo E. Diagnosis and treatment of vitamin B12 deficiency-an update. Haematologica 2006, 91:1506-1512.
2. Berlin H., Berlin R., Brante E. Oral treatment of pernicious anemia with high doses of vitamin B12 without intrinsic factor. Acta Med Scand 1968, 184:247-258.
3. Carmel R. Efficacy and safety of fortification and supplementation with vitamin B12: biochemical and physiological effects. Food Nutr Bull 2008, 29:S177-S187.
4. Kuzminski A.M., Del Giacco E.J., Allen R.H., et al. Effective treatment of cobalamin deficiency with oral cobalamin. Blood 1998, 92:1191-1198.
5. Bolaman Z., Kadikoylu G., Yukselen V., et al. Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study. Clin Ther 2003, 25:3124-3134.
6. Butler C.C., Vidal-Alaball J., Cannings-John R., et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency: a systematic review of randomized controlled trials. Fam Pract 2006, 23:279-285.
7. Andrès E., Kurtz J.E., Perrin A.E., et al. Oral cobalamin therapy for the treatment of patients with food-cobalamin malabsorption. Am J Med 2001, 111:126-129.
8. Andrès E., Loukili N.H., Noel E., et al. Effects of oral crystalline cyanocobalamin 1000 μg/d in the treatment of pernicious anemia: an open-label, prospective study in ten patients. Curr Ther Res Clin Exp 2005, 66:13-22.
9. Andrès E., Serraj K., Federici L., et al. Efficacité au long cours d'un traitement par cyanocobalamine administrée par voie orale dans le cadre des carences en vitamine B12: étude de 22 cas. Rev Med Interne 2007, 28(Suppl 1):49.
10. Andrès E., Perrin A.E., Demangeat C., et al. The syndrome of food-cobalamin malabsorption revisited in a department of internal medicine. A monocentric cohort study of 80 patients. Eu J Intern Med 2003, 14:221-226.
11. Kaltenbach G., Noblet-Dick M., Andrès E., et al. Early response to oral cobalamin therapy in older patients with vitamin B12 deficiency [in French]. Ann Med Interne (Paris) 2003, 154:91-95.
12. Hoey L., Strain J.J., McNulty H. Studies of biomarker responses to intervention with vitamin B-12: a systematic review of randomized controlled trials. Am J Clin Nutr 2009, 89(Suppl):1981S-1996S.
13. Lane L.A., Rojas-Fernandez C. Treatment of vitamin b(12)-deficiency anemia: oral versus parenteral therapy. Ann Pharmacother 2002, 36:1268-1272.
14. Alani A.W., Robinson J.R. Mechanistic understanding of oral drug absorption enhancement of cromolyn sodium by an amino acid derivative. Pharm Res 2008, 25:48-54.
15. Schilling R.F. Pernicious anemia. JAMA 1985, 253:94.
16. Herrmann W., Obeid R., Schorr H., Geisel J. Functional vitamin B12 deficiency and determination of holotranscobalamin in populations at risk. Clin Chem Lab Med 2003, 41:1478-1488.
17. Dawson-Saunders B., Trapp R.G. Basic and Clinical Biostatistics 1994, Appleton & Lange, Norwalk, Conn. 2nd ed.
18. Herbert V. Staging vitamin B-12 (cobalamin) status in vegetarians. Am J Clin Nutr 1994, 59(Suppl 5):1213S-1222S.
19. Eussen S.J., Ueland P.M., Hiddink G.J., et al. Changes in markers of cobalamin status after cessation of oral B-vitamin supplements in elderly people with mild cobalamin deficiency. Eur J Clin Nutr 2008, 62:1248-1251.
20. Axsym B12 [package insert] 2007, Abbott Laboratories Inc, Abbott Park, Ill.
21. Ross G.I., Mollin D.L., Cox E.V., Ungley C.C. Hematologic responses and concentration of vitamin B12 in serum and urine following oral administration of vitamin B12 without intrinsic factor. Blood 1954, 9:473-488.
22. Adams J.F. The urinary excretion and tissue retention of cyanocobalamin by subjects given repeated parenteral doses. J Clin Pathol 1964, 17:31-38.
23. Mollin D.L., Pitney W.R., Baker S.J., Bradley J.E. The plasma clearance and urinary excretion of parenterally administered 58Co B12. Blood 1956, 11:31-43.
24. Mollin D.L., Ross G.I. Vitamin B12 concentrations of serum and urine in the first 72 hours after intramuscular injections of the vitamin. J Clin Pathol 1953, 6:54-61.
25. Stabler S.P., Allen R.H., Savage D.G., Lindenbaum J. Clinical spectrum and diagnosis of cobalamin deficiency. Blood 1990, 76:871-881.
26. Green R. Metabolite assays in cobalamin and folate deficiency. Baillieres Clin Haematol 1995, 8:533-566.
27. Ding X., Rath P., Angelo R., et al. Oral absorption enhancement of cromolyn sodium through noncovalent complexation. Pharm Res 2004, 21:2196-2206.
28. Hess S., Rotshild V., Hoffman A. Investigation of the enhancing mechanism of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate effect on the intestinal permeability of polar molecules utilizing a voltage clamp method. Eur J Pharm Sci 2005, 25:307-312.
29. DeSesso J.M., Jacobson C.F. Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats. Food Chem Toxicol 2001, 39:209-228.
30. Karsdal M.A., Byrjalsen I., Riis B.J., Christiansen C. Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: the effect of water and timing of meal intake on oral delivery of Salmon Calcitonin. BMC Clin Pharmacol 2008, 8:5.
31. Doscherholmen A., Hagen P.S. A dual mechanism of vitamin B12 plasma absorption. J Clin Invest 1957, 36:1551-1557.
32. ICH harmonised tripartite guideline. Ethnic factors in the acceptability of foreign clinical data: E5(R1). Accessed February 16, 2011. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E5_R1/Step4/E5_R1__Guideline.pdf.
33. DRI: Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic acid, Biotin, and Choline 1998, 306-356. Institute of Medicine, National Academy Press, Washington DC.